Millennium Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Millennium Management's MXCT Position: Q1 2026 in Review
Millennium Management reduced its MaxCyte (MXCT) stake by 97% in Q1 2026, selling an estimated $1.17M and leaving 43,059 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5474.
Millennium Management first reported a position in MXCT in Q3 2021 and has held it in 18 quarters since. The position peaked at $25.9M in Q1 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Millennium Management held 43,059 shares of MaxCyte worth $30.2K as of Q1 2026.
- Millennium Management sold 1,249,714 MaxCyte shares in Q1 2026, an estimated $1.17M.
- MaxCyte made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5474 holding.
- Millennium Management first reported a position in MaxCyte in Q3 2021 and has held it in 18 quarters since.
- Millennium Management's MaxCyte position peaked at $25.9M in Q1 2024.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.